ArticleInternal and emergency medicine2025
Global, regional, and national burden of aortic aneurysm disease and its attributable risk factor, 1990-2021: a systematic analysis for the global burden of disease study 2021.
Article in Internal and emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- The Global Burden of Aortic Aneurysm and Its Attributable Risk Factors, 1990-2021: Results from the Global Burden of Disease Study 2021.Health science reports · 2026Article
- Integrin Signaling Pathways in Aortic Aneurysm and Dissection.Reviews in cardiovascular medicine · 2026Review
- Burden of aortic aneurysm and lead exposure risk factor in adults aged 60 years and older from 1990 to 2021: a global, regional, and national analysis.Frontiers in public health · 2026Article
- The global burden of aortic aneurysm attributable to smoking from 1990 to 2021: Current trends and projections for 2036.Tobacco induced diseases · 2026Article
- Therapeutic Targeting of Signaling Pathways in Abdominal Aortic Aneurysm: From Pathogenesis to Precision Medicine.Drug design, development and therapy · 2025Review
- Microarray Analysis of Human Abdominal Aortic Aneurysm With Emphasis on Cardiovascular Genes Revealed Differentially Expressed Genes.In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study aimed to evaluate the global, regional, and national burden of aortic aneurysms and their attributable risk factors from 1990 to 2021. Data from the global burden of disease 2021 study were used to analyze aortic aneurysm death numbers, age-standardized death rates (ASDR), and attributable risk factors across age, sex, region, and the Socio-demographic Index (SDI). Temporal trends were assessed by estimated annual percentage change (EAPC). Pearson correlation analysis evaluated the relationship between disease burden and covariates. In 2021, aortic aneurysm caused 153,927 deaths [95% uncertainty intervals (UI), 138,413-165,739], with an ASDR of 1.86 per 100,000 (95% UI 1.67-2.00). From 1990 to 2021, deaths increased by 74.2% (95% UI 56.4-94.0), while ASDR decreased by 26.8% (95% UI 18.0-34.6) with an EAPC of - 1.28% [95% confidence interval (CI), - 1.38 to - 1.18%]. Male ASDR was 2.25 times higher than females (95% UI 1.90-2.77) and correlated with SDI (R = 0.469, p < 0.001). The highest ASDR was in the High-income Asia Pacific (4.38 per 100,000; 95% UI 3.72-4.75). Smoking, the leading risk factor, accounted for 30.9% of ASDR (95% UI 26.3-35.8%). Projections estimate that deaths will rise to 174,611 (95% UI 163,289-185,933), with ASDR declining to 1.70 per 100,000 (95% UI 1.45-1.96) in 2030. Aortic aneurysm burden varies by age, sex, and region. Despite declining ASDR, it remains an emerging global public health issue driven by aging populations and shifting risk factors, requiring innovative prevention and healthcare strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.